EQL Pharma AB (publ) (STO:EQL)
Sweden · Delayed Price · Currency is SEK 22.85
+0.50 (2.24%)
At close: Oct 14, 2026
EQL Pharma AB Market Cap
EQL Pharma AB has a market cap or net worth of 674.75 million as of October 14, 2026. It is the 28,082nd most valuable company in the world and the 353rd biggest in Sweden. Its market cap has decreased by 62.23% in one year.
Market Cap
674.75M
Enterprise Value
1.07B
Revenue
432.35M
Global Rank
Country Rank
#353 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since December 17, 2013, EQL Pharma AB's market cap has increased from 78.22M to 674.75M, an increase of 762.61%. That is a compound annual growth rate of 18.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2026 | 674.75M | -60.47% |
| Dec 30, 2025 | 1.71B | -27.50% |
| Dec 30, 2024 | 2.35B | 142.51% |
| Dec 29, 2023 | 970.72M | 16.78% |
| Dec 30, 2022 | 831.22M | -26.29% |
| Dec 30, 2021 | 1.13B | -2.27% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nanexa AB | 1.95B |
| Cereno Scientific AB | 1.12B |
| Dicot Pharma AB | 856.07M |
| Cinclus Pharma Holding AB | 590.10M |
| Moberg Pharma AB | 535.03M |
| Enzymatica AB | 427.21M |
| Orexo AB | 223.92M |
| Klaria Pharma Holding AB (publ.) | 121.14M |